Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Angiology
Clinical Trial Begins for Innovative Drug-Eluting Stent with Unique Reservoir Technology
April 11th, 2008
A randomized clinical trial comparing the Conor Sirolimus-eluting Coronary Stent, a new cobalt chromium reservoir-base stent design, to the Taxus Liberte Paclitaxel-eluting Coronary Stent has begun according to Conor Medsystems, LLC and Cordis Corporation, the sponsors of the study. "We are pleased that the RES-ELUTION trial has begun and that the first patient enrolled in this study occurred at our hospital. The product was easily delivered and performed well," said John Ormiston, M.D., North Shore Hospital, Auckland, New Zealand and Principal Investigator for this study. "The potential of sirolimus delivery from a fully-bioresorbable reservoir is exciting and may...
Source: Health Business Week (2008-04-11)
|
